JAGUAR HEALTH INC (JAGX) Stock Analyst Earnings Estimates
NASDAQ:JAGX - Nasdaq - US47010C8055 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.335M -53.81% | 11.956M 175.80% | 9.761M -18.36% | 11.536M 18.18% | 16.157M 40.06% | 22.613M 39.96% | 204M 802.14% | 389.44M 90.90% | 573.95M 47.38% | 682.99M 19.00% | |
| EBITDA YoY % growth | -37.355M -90.81% | -32.434M 13.17% | -31.907M 1.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.074M -83.41% | -34.415M 11.92% | -33.92M 1.44% | -29.825M 12.07% | -24.888M 16.55% | -18.329M 26.35% | 105.67M 676.51% | 260.3M 146.33% | 415.85M 59.76% | 509.49M 22.52% | |
| Operating Margin | -901.36% | -287.85% | -347.51% | -258.54% | -154.04% | -81.06% | 51.80% | 66.84% | 72.45% | 74.60% | |
| EPS YoY % growth | -5,310.00 64.24% | N/A 98.89% | N/A 89.90% | -0.82 86.28% | -2.10 -157.50% | -0.99 52.91% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.70 -70.41% | -0.88 79.11% | -0.77 81.06% | -0.57 45.60% | -0.51 70.06% | -0.56 36.05% | -0.58 24.00% | -0.38 33.93% | -0.36 30.00% |
| Revenue Q2Q % growth | 3.727M 62.04% | 3.837M 63.21% | 3.885M 42.78% | 5.463M 75.77% | 5.367M 44.00% | 6.139M 59.99% | 5.44M 40.03% | 7.43M 36.01% | 7.729M 44.01% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.293M 12.42% | -6.406M 22.03% | -6.253M 13.12% | -5.12M 29.49% | -5.039M 19.94% | -3.845M 39.97% | -4.641M 25.77% | -3.172M 38.05% | -3.264M 35.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.05 96.82% | -2.42 | 1.37 | 56.56% |
| Q2 2024 Q2Q % growth | -4.04 90.24% | -1.22 | -2.82 | -230.07% |
| Q1 2024 Q2Q % growth | -4.20 -6,762.75% | -1.84 | -2.36 | -128.76% |
| Q4 2023 Q2Q % growth | 89.95% | -1.00 | % | |
| Q3 2023 Q2Q % growth | -33.00 93.89% | -75.28 | 42.28 | 56.16% |
| Q2 2023 Q2Q % growth | -41.40 92.33% | -93.64 | 52.24 | 55.79% |
| Q1 2023 Q2Q % growth | 100.00% | -0.06 | % | |
| Q4 2022 Q2Q % growth | 99.29% | -9.95 | % | |
| Q3 2022 Q2Q % growth | -540.00 55.56% | -344.25 | -195.75 | -56.86% |
| Q2 2022 Q2Q % growth | -540.00 60.00% | -1,009.80 | 469.80 | 46.52% |
| Q1 2022 Q2Q % growth | -1,800.00 -33.33% | -803.25 | -996.75 | -124.09% |
| Q4 2021 Q2Q % growth | -1,395.00 31.11% | -413.10 | -981.90 | -237.69% |
| Q3 2021 Q2Q % growth | -1,215.00 57.14% | -803.25 | -411.75 | -51.26% |
| Q2 2021 Q2Q % growth | -1,350.00 65.52% | -550.80 | -799.20 | -145.10% |
| Q1 2021 Q2Q % growth | -1,350.00 77.78% | -275.40 | -1,074.60 | -390.20% |
| Q4 2020 Q2Q % growth | -2,025.00 70.98% | -1,377.00 | -648.00 | -47.06% |
| Q3 2020 Q2Q % growth | -2,835.00 88.89% | -1,514.70 | -1,320.30 | -87.17% |
| Q2 2020 Q2Q % growth | -3,915.00 96.81% | -2,065.50 | -1,849.50 | -89.54% |
| Q1 2020 Q2Q % growth | -6,075.00 96.43% | -3,167.10 | -2,907.90 | -91.82% |
| Q3 2019 Q2Q % growth | -25,515.00 | -17,143.65 | -8,371.35 | -48.83% |
| Q2 2019 Q2Q % growth | -122,715.00 | -72,843.30 | -49,871.70 | -68.46% |
| Q1 2019 Q2Q % growth | -170,100.00 | -183,141.00 | 13,041.00 | 7.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.108M 10.49% | 4.017M | -909K | -22.63% |
| Q2 2024 Q2Q % growth | 2.721M 1.68% | 3.494M | -773K | -22.12% |
| Q1 2024 Q2Q % growth | 2.351M 19.22% | 3.017M | -666K | -22.07% |
| Q4 2023 Q2Q % growth | 2.3M -29.45% | 2.662M | -362K | -13.60% |
| Q3 2023 Q2Q % growth | 2.813M -10.70% | 2.509M | 304K | 12.12% |
| Q2 2023 Q2Q % growth | 2.676M -8.39% | 2.326M | 350K | 15.05% |
| Q1 2023 Q2Q % growth | 1.972M -24.88% | 3.978M | -2.006M | -50.43% |
| Q4 2022 Q2Q % growth | 3.26M 56.73% | 2.04M | 1.22M | 59.80% |
| Q3 2022 Q2Q % growth | 3.15M 400.00% | 3.621M | -471K | -13.01% |
| Q2 2022 Q2Q % growth | 2.921M 658.70% | 3.162M | -241K | -7.62% |
| Q1 2022 Q2Q % growth | 2.625M 111.52% | 1.652M | 973K | 58.90% |
| Q4 2021 Q2Q % growth | 2.08M -19.25% | 8.548M | -6.468M | -75.67% |
| Q3 2021 Q2Q % growth | 630K -77.28% | 2.683M | -2.053M | -76.52% |
| Q2 2021 Q2Q % growth | 385K -87.84% | 5.049M | -4.664M | -92.37% |
| Q1 2021 Q2Q % growth | 1.241M 42.81% | 7.548M | -6.307M | -83.56% |
| Q4 2020 Q2Q % growth | 2.576M 70.92% | 2.346M | 230K | 9.80% |
| Q3 2020 Q2Q % growth | 2.773M 185.05% | 7.956M | -5.183M | -65.15% |
| Q2 2020 Q2Q % growth | 3.167M 85.67% | 4.874M | -1.707M | -35.02% |
| Q1 2020 Q2Q % growth | 869K -45.34% | 2.545M | -1.676M | -65.85% |
| Q4 2019 Q2Q % growth | 1.507M | 4.028M | -2.521M | -62.58% |
| Q3 2019 Q2Q % growth | 972.8K | 2.92M | -1.947M | -66.68% |
| Q2 2019 Q2Q % growth | 1.706M | 3.06M | -1.354M | -44.26% |
| Q1 2019 Q2Q % growth | 1.59M | 2.244M | -654.3K | -29.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -39.17% | 0% | -2.56% |
| Revenue | 0% | -6.66% | 0% | -10.69% |